FDA.reportPublic FDA data

Xelprox 0.005 % Ophthalmic Emulsion

RxCUI
2056748
RxNorm name
Xelprox 0.005 % Ophthalmic Emulsion
Display name
Xelprox 0.005 % Ophthalmic Emulsion
Full name
Xelprox 0.005 % Ophthalmic Emulsion
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XELPROSLATANOPROSTSun Pharmaceutical Industries, Inc.34ad5cf6-4df0-4104-bddd-4c7631133ded2025-12-18Warnings, Adverse reactionsExact identifier
rxcui: 2056748

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
34ad5cf6-4df0-4104-bddd-4c7631133dedXelprox 0.005 % Ophthalmic Emulsion [PSN] · latanoprost 0.05 MG/ML Ophthalmic Suspension [Xelpros] [SBD] · Xelpros 0.05 MG/ML Ophthalmic Emulsion [SY] · Xelpros 0.05 MG/ML Ophthalmic Suspension [SY]411These highlights do not include all the information needed to use XELPROS safely and effectively. See full prescribing information for XELPROS. XELPROS ® (latanoprost ophthalmic emulsion) 0.005%, for topical ophthalmic use Initial U.S. Approval: 199620251218